Author: CATIE | Page 4

Bridging a gap: Foundational harm reduction education for frontline workers

April 26, 2022 • By Camille Arkell

For many years, CATIE has promoted the importance of harm reduction as a strategy to prevent HIV and hepatitis C among people who use drugs. Through our work, we have developed strong partnerships with harm reduction service providers, educators and advocates. More recently, we have responded to the needs of our partners by expanding the scope of our harm reduction information and education work to cover harm reduction and the health and rights of people who use drugs more broadly.

The future of PrEP is now!

March 25, 2022 • By Darrell H. S. Tan, MD, FRCPC, PhD

A few days before ringing in the New Year, I received an email notification that got me super excited about the future of HIV prevention. I needed the boost – the omicron surge of COVID-19 was just starting to tear through communities across the country, and had even hit my own household, making for a painfully lonely holiday season just as my husband and our kids were starting the school winter break.

HIV Made Me Fabulous: Celebrating positive women

February 11, 2022 • By Zoë Osborne and Azra Bhanji

Using Valentine’s Day as a backdrop, Love Positive Women is an annual celebration of women living with HIV. As we honour the positive women around the globe, we must also address the inequities that they face navigating sex, dating and love. How can we ensure that the rights of women living with HIV to have pleasurable and satisfying relationships are protected, supported and uplifted?

Rapid tests for the diagnosis of syphilis and HIV: A potential game changer for Canada

February 2, 2022 • By Ameeta Singh and Jennifer Gratrix

Syphilis is a sexually transmitted infection that is on the rise in Canada, with many areas experiencing outbreaks. In 2019, the Alberta Chief Medical Officer of Health declared an outbreak after observing a rise in cases not seen since 1948!

What I learned from teaching an HIV and hepatitis C testing course

February 2, 2022 • By Shelley Taylor

HIV treatments are a literal lifesaver and help people to live long and healthy lives, while also preventing transmission. There are also highly effective hepatitis C treatments that cure more than 95% of those living with the infection. But none of the advancements in hepatitis C and HIV treatment are being realized for the 13% of HIV-positive Canadians and 44% of Canadians with hepatitis C who don’t know their status. Testing is the first step towards connecting people to treatment, care and support, and no matter the result, it can also be the gateway to prevention services like harm reduction...

Helping harm reduction programs move towards best practices

December 15, 2021 • By Carol Strike

For harm reduction programs across Canada, the distribution of injection, smoking and snorting/sniffing supplies remains a crucial activity to reduce drug-related harms. While estimates of the number of people who use drugs from unregulated markets are imprecise, the evidence that does exist suggests that more than 170,000 Canadians inject drugs and 730,000 used cocaine or crack in the past year (1). Population estimates of the number of Canadians who used crystal methamphetamine are not available. The rates of needle/syringe sharing in Canada have dropped in the past 20 years to just over 10% among people who inject drugs, but more...